RNA and Toll-Like Receptor 7 License the Generation of Superior Secondary Plasma Cells at Multiple Levels in a B Cell Intrinsic Fashion

Front Immunol. 2019 Apr 5:10:736. doi: 10.3389/fimmu.2019.00736. eCollection 2019.

Abstract

Secondary plasma cells (PCs) originate from memory B cells and produce increased levels of antibodies with higher affinity compared to PCs generated during primary responses. Here we demonstrate that virus-like particles (VLPs) only induce secondary PCs in the presence of toll-like receptor (TLR) 7 and if they are loaded with RNA. Furthermore, adoptive transfer experiments demonstrate that RNA and TLR7 signaling are required for secondary PC generation, both at the level of memory B cell as well as PC differentiation. TLR7-signaling occurred in a B cell intrinsic manner as TLR7-deficient B cells in an otherwise TLR7-competent environment failed to differentiate into secondary PCs. Therefore, RNA inside VLPs is essential for the generation of memory B cells, which are competent to differentiate to secondary PCs and for the differentiation of secondary PCs themselves. While we have not tested all other TLR or non-TLR adjuvants with our VLPs, these data have obvious implications for vaccine design, as RNA packaged into VLPs is a simple way to enhance induction of memory B cells capable of generating secondary PCs.

Keywords: adaptive immunity; anti-viral immunity; memory B cells; secondary plasma cells; toll-like receptor 7; virus-like particles.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adjuvants, Immunologic / metabolism*
  • Animals
  • Antibodies, Viral / metabolism
  • Antibody Affinity
  • B-Lymphocytes / immunology*
  • Cell Differentiation
  • Cells, Cultured
  • Humans
  • Immunologic Memory
  • Mice
  • Mice, Inbred C57BL
  • Plasma Cells / immunology*
  • RNA / genetics*
  • RNA / metabolism*
  • Signal Transduction
  • Toll-Like Receptor 7 / genetics
  • Toll-Like Receptor 7 / metabolism*
  • Vaccines, Virus-Like Particle / immunology*
  • Virion

Substances

  • Adjuvants, Immunologic
  • Antibodies, Viral
  • TLR7 protein, human
  • Toll-Like Receptor 7
  • Vaccines, Virus-Like Particle
  • RNA